The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment
Open accessAbstract
Enterobacter aerogenes and E. cloacae have been reported as important opportunistic and multiresistant bacterial pathogens for humans during the last three decades in hospital wards. These Gram-negative bacteria have been largely described during several outbreaks of hospital-acquired infections in Europe and particularly in France. The dissemination of Enterobacter sp. is associated with the presence of redundant regulatory cascades that efficiently control the membrane permeability ensuring the bacterial protection and the expression of detoxifying enzymes involved in antibiotic degradation/inactivation. In addition, these bacterial species are able to acquire numerous genetic mobile elements that strongly contribute to antibiotic resistance. Moreover, this particular fitness help them to colonize several environments and hosts and rapidly and efficiently adapt their metabolism and physiology to external conditions and environmental stresses. Enterobacter is a versatile bacterium able to promptly respond to the antibiotic treatment in the colonized patient. The balance of the prevalence, E. aerogenes versus E. cloacae, in the reported hospital infections during the last period, questions about the horizontal transmission of mobile elements containing antibiotic resistance genes, e.g., the efficacy of the exchange of resistance genes Klebsiella pneumoniae to Enterobacter sp. It is also important to mention the possible role of antibiotic use in the treatment of bacterial infectious diseases in this E. aerogenes/E. cloacae evolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231 · cited 2×
“The EefABC and AcrAB–TolC efflux genes of E. aerogenes have been described and their involvement in antibiotic exportation has been studied (Pradel and Pagès, 2002; Masi et al., 2005, 2006; Martins et al., 2010).”
BackgroundThe porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
Pagès, J.-M., James, C. E., & Winterhalter, M. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1994 · Cited by 939
Self-citationBroad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria
Nikaido, H., & Pagès, J.-M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00290.x · Cited by 769
Self-citationFarmer, J. J., Davis, B. R., Hickman-Brenner, F. W., McWhorter, A., Huntley-Carter, G. P., Asbury, M. A., Riddle, C., Wathen-Grady, H. G., Elias, C., & Fanning, G. R. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.21.1.46-76.1985 · Cited by 707
Structure of the AcrAB–TolC multidrug efflux pump
Du, D., Wang, Z., James, N. R., Voss, J. E., Klimont, E., Ohene-Agyei, T., Venter, H., Chiu, W., & Luisi, B. F. (2014) · Nature · doi:10.1038/nature13205 · Cited by 662
Enterobacter cloacae Complex: Clinical Impact and Emerging Antibiotic Resistance
Mezzatesta, M. L., Gona, F., & Stefani, S. (2012) · Future Microbiology · doi:10.2217/fmb.12.61 · Cited by 562
Enterobacter spp.: pathogens poised to flourish at the turn of the century
Sanders, W. E., & Sanders, C. C. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.2.220 · Cited by 532
Doumith, M., Ellington, M. J., Livermore, D. M., & Woodford, N. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp029 · Cited by 450
Active efflux, a common mechanism for biocide and antibiotic resistance
Levy, S. B. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.4.x · Cited by 401
Progress and Challenges in Implementing the Research on ESKAPE Pathogens
Rice, L. B. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/655995 · Cited by 370
Carbapenemases: Molecular Diversity and Clinical Consequences
Poirel, L., Pitout, J. D., & Nordmann, P. (2007) · Future Microbiology · doi:10.2217/17460913.2.5.501 · Cited by 309
Potron, A., Poirel, L., Rondinaud, E., & Nordmann, P. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.31.20549 · Cited by 289
Membrane Permeability and Regulation of Drug “Influx and Efflux” in Enterobacterial Pathogens
Davin-Regli, A., Bolla, J.-M., James, C., Lavigne, J.-P., Chevalier, J., Garnotel, E., Molitor, A., & Pages, J.-M. (2008) · Current Drug Targets · doi:10.2174/138945008785747824 · Cited by 188
Self-citationMallea, M., Chevalier, J., Bornet, C., Eyraud, A., Davin-Regli, A., Bollet, C., & Pages, J.-M. (1998) · Microbiology · doi:10.1099/00221287-144-11-3003 · Cited by 177
Self-citationPradel, E., & Pagès, J.-M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2640-2643.2002 · Cited by 163
Nordmann, P., Mariotte, S., Naas, T., Labia, R., & Nicolas, M. H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.939 · Cited by 161
Dé, E., Baslé, A., Jaquinod, M., Saint, N., Malléa, M., Molle, G., & Pagès, J. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02501.x · Cited by 156
Self-citationDiene, S. M., Merhej, V., Henry, M., Filali, A. E., Roux, V., Robert, C., Azza, S., Gavory, F., Barbe, V., Scola, B. L., et al. (2012) · Molecular Biology and Evolution · doi:10.1093/molbev/mss236 · Cited by 151
Imipenem Resistance of Enterobacter aerogenes Mediated by Outer Membrane Permeability
Bornet, C., Davin‐Regli, A., Bosi, C., Pagès, J., & Claude Bollet, C. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1048-1052.2000 · Cited by 144
Self-citationCharrel, R. N., Pagès, J., de Micco, P., & Malléa, M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.12.2854 · Cited by 123
Self-citationMasi, M., & Pagès, J. (2013) · The Open Microbiology Journal · doi:10.2174/1874285801307010022 · Cited by 122
Self-citationCORKILL, J. E., Anson, J. J., & Hart, C. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki388 · Cited by 105
How β-Lactam Antibiotics Enter Bacteria: A Dialogue with the Porins
James, C. E., Mahendran, K. R., Molitor, A., Bolla, J., Bessonov, A. N., Winterhalter, M., & Pagès, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005453 · Cited by 104
Self-citationMost Enterobacter aerogenes Strains in France Belong to a Prevalent Clone
Bosi, C., Davin‐Regli, A., Bornet, C., Malléa, M., Pagès, J., & Claude Bollet, C. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2165-2169.1999 · Cited by 101
Self-citationMolecular characterization of an Enterobacter cloacae outer membrane protein (OmpX)
Stoorvogel, J., van Bussel, M. J., Tommassen, J., & van de Klundert, J. A. M. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.1.156-160.1991 · Cited by 98
RamA Is an Alternate Activator of the Multidrug Resistance Cascade in Enterobacter aerogenes
Chollet, R., Chevalier, J., Claude Bollet, C., Pagès, J., & Davin‐Regli, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2518-2523.2004 · Cited by 95
Self-citationUnique epidemiology of nosocomial urinary tract infection in children
Langley, J. M., Hanakowski, M., & LeBlanc, J. C. (2001) · American Journal of Infection Control · doi:10.1067/mic.2001.111537 · Cited by 94
Cross-resistance between biocides and antimicrobials: an emerging question
Davin‐Regli, A., & Pagès, J. (2012) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.31.1.2099 · Cited by 91
Self-citationQuiroga, M. P., Andres, P. O., Petroni, A., Soler‐Bistué, A., Guerriero, L., Vargas, L. J., Zorreguieta, Á., Tokumoto, M., Quiroga, C., Tolmasky, M. E., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00726-07 · Cited by 90
Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins
Raimondi, A., Traverso, A., & Nikaido, H. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1174 · Cited by 89
Thiolas, A., Bornet, C., Davin‐Regli, A., Pagès, J., & Claude Bollet, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.130 · Cited by 88
Self-citationThiolas, A., Bollet, C., Scola, B. L., Raoult, D., & Pagès, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1354-1358.2005 · Cited by 87
Self-citationLavigne, J., Sotto, A., Nicolas-Chanoine, M.-H., Bouziges, N., Pagès, J., & Davin‐Regli, A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.10.010 · Cited by 84
Self-citationAssociation of Plasmid-Mediated Quinolone Resistance with Extended-Spectrum β-Lactamase VEB-1
Poirel, L., Loo, M. V. D., Mammeri, H., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.3091-3094.2005 · Cited by 77
Dupont, M., James, C. E., Chevalier, J., & Pagès, J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01481-06 · Cited by 75
Self-citationHuang, S., Dai, W., Sun, S., Zhang, X., & Zhang, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047636 · Cited by 72
Yigit, H., Anderson, G. J., Biddle, J. W., Steward, C. D., Rasheed, J. K., Valera, L., McGowan, J. E., & Tenover, F. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3817-3822.2002 · Cited by 68
Gayet, S., Chollet, R., Molle, G., Pagès, J., & Chevalier, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1555-1559.2003 · Cited by 66
Self-citationFernández‐Baca, V., Ballesteros, F., Hervás, J. A., Villalón, P., Domínguez, M. Á., Benedi, V. J., & Albertí, S. (2001) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1053 · Cited by 65
Lavigne, J.-P., Sotto, A., Nicolas-Chanoine, M.-H., Bouziges, N., Bourg, G., Davin‐Regli, A., & Pagès, J. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03607.x · Cited by 64
Self-citationChevalier, J., Mulfinger, C., Garnotel, É., Nicolas, P., Davin‐Regli, A., & Pagès, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003203 · Cited by 62
Self-citationPérez, A., Canle, D., Latasa, C., Poza, M., Beceiro, A., Tomás, M., Fernández, A., Mallo, S., Pérez‐Castro, S., Molina, F., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00072-07 · Cited by 62
mar Operon Involved in Multidrug Resistance of Enterobacter aerogenes
Chollet, R., Bollet, C., Chevalier, J., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1093-1097.2002 · Cited by 59
Chevalier, J., Malléa, M., & Pagès, J. (2000) · Biochemical Journal · doi:10.1042/bj3480223 · Cited by 58
Self-citationDetection of the carbapenemase GIM-1 in Enterobacter cloacae in Germany
Hamprecht, A. G., Poirel, L., Göttig, S., Seifert, H., Kaase, M., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks447 · Cited by 56
Susceptibilities to antibiotics and antiseptics of new species of the family Enterobacteriaceae
Freney, J., Husson, M., Gavini, F., Madier, S., Martra, A., Izard, D., Leclerc, H., & Fleurette, J. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.6.873 · Cited by 54
Toward Screening for Antibiotics with Enhanced Permeation Properties through Bacterial Porins
Hajjar, E., Bessonov, A. N., Molitor, A., Kumar, A., Mahendran, K. R., Winterhalter, M., Pagès, J., Ruggerone, P., & Ceccarelli, M. (2010) · Biochemistry · doi:10.1021/bi100845x · Cited by 53
Self-citationβ-Lactam Screening by Specific Residues of the OmpF Eyelet
Vidal, S., Bredin, J., Pagès, J., & Barbe, J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049652e · Cited by 53
Self-citationGenetic inactivation of acrAB or inhibition of efflux induces expression of ramA
Lawler, A. J., Ricci, V., Busby, S. J. W., & Piddock, L. J. V. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt069 · Cited by 53
Robert, J., Pantel, A., Mérens, A., Lavigne, J., Nicolas-Chanoine, M.-H., Brieu, N., Vrain, A., Scanvic, A., Porcheret, H., Garnier, P., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku208 · Cited by 50
Hajjar, E., Mahendran, K. R., Kumar, A., Bessonov, A. N., Petrescu, M., Weingart, H., Ruggerone, P., Winterhalter, M., & Ceccarelli, M. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.10.045 · Cited by 50
Galas, M., Decousser, J., Breton, N., Godard, T., Allouch, P., & Pina, P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00906-07 · Cited by 47
In Vivo Modification of Porin Activity Conferring Antibiotic Resistance to Enterobacter aerogenes
Chevalier, J., Pagès, J., & Malléa, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1795 · Cited by 45
Self-citationLee, S. H., Jeong, S. H., & Park, Y. M. (2003) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2003.02040.x · Cited by 39
Park, Y.-J., Yu, J. K., Kim, S.-I., Lee, K., & Arakawa, Y. (2009) · PubMed · Cited by 35
Song, E. H., Park, K., Jang, E.-Y., et al. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.11.007 · Cited by 35
Kim, S. Y., Park, Y.-J., Yu, J. K., Kim, Y. S., & Han, K. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.11.016 · Cited by 33
Kanamori, H., Yano, H., Hirakata, Y., Hirotani, A., Arai, K., Endo, S., Ichimura, S., Ogawa, M., Shimojima, M., Aoyagi, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037967 · Cited by 32
Lee, H. K., Park, Y.-J., Kim, J., Chang, E.-D., Cho, S., Chae, H. S., & Kang, C. S. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.04.012 · Cited by 31
Jaskulski, M. D. R., Medeiros, B. C., Borges, J. V., Zalewsky, R., Fonseca, M. E. C., Marinowic, D. R., da Rocha, M. P., Nodari, P., & Machado, D. C. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.03.009 · Cited by 26
Szabó, D., Melan, M. A., Hujer, A. M., Bonomo, R. A., Hujer, K. M., Bethel, C. R., Kristóf, K., & Paterson, D. L. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4716-4720.2005 · Cited by 25
Masi, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl139 · Cited by 24
Anastay, M., Lagier, E., Blanc, V., & Chardon, H. (2012) · Pathologie Biologie · doi:10.1016/j.patbio.2012.03.001 · Cited by 19
Hammami, S., Boubaker, I. B.-B., Saïdani, M., Lakhal, E., Hassen, A. B., Kamoun, A., Ghozzi, R., Slim, A., & Redjeb, S. B. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0074 · Cited by 15
Tran, Q., Dupont, M., Lavigne, J., Chevalier, J., Pagès, J., Sotto, A., & Davin‐Regli, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00822-08 · Cited by 13
Self-citationBacterial Membrane, a Key for Controlling Drug Influx and Efflux
Valade, E., Davin‐Regli, A., Bolla, J., & Pagès, J. (2013) · Antibiotics · doi:10.1002/9783527659685.ch9 · Cited by 7
Self-citation
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Ectopic colonization of oral bacteria in the intestine drives T H 1 cell induction and inflammation
Atarashi, K., Suda, W., Luo, C., Kawaguchi, T., Motoo, I., Narushima, S., Kiguchi, Y., Yasuma, K., Watanabe, E., Tanoue, T., et al. (2017) · Science · doi:10.1126/science.aan4526 · Cited by 957
Enterobacter spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance
Davin-Regli, A., Lavigne, J.-P., & Pagès, J.-M. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-19 · Cited by 570
Self-citationLeonard, A. F. C., Zhang, L., Balfour, A. J., Garside, R., Hawkey, P. M., Murray, A. K., Ukoumunne, O. C., & Gaze, W. H. (2018) · Environment International · doi:10.1016/j.envint.2017.11.003 · Cited by 282
Metadata
- Authors
- Davin-Regli, A., & Pagès, J.-M.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2015-05-18
- Volume
- 6
- Pages
- 392-392
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W1848139833
- Cited by
- 627
- References
- 68
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.